Fresenius Medical Care | FME - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Akzo Nobel EUR -73M 324M 2026-09
Alcon AG USD 44M 253M 2026-06
AstraZeneca USD 4.66B 1.5B 2026-09
Bayer EUR 129M 698M 2026-09
Beiersdorf EUR 760M 256M 2026-06
DaVita Healthcare Partners USD 570.82M 97.27M 2026-06
Demant DKK 2.12B 35M 2026-06
E.ON EUR 1.14B 2.97B 2026-06
Essilor EUR 2.3B 919M 2026-06
Fresenius EUR 639M 80M 2026-09
Fresenius Medical Care EUR 384M 153.27M 2026-09
Genmab DKK 407M 182M 2026-06
Getinge SEK 1.35B 268M 2026-06
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 2.86B 251M 2026-09
GN Store Nord DKK 310M 252M 2026-09
GRIFOLS EUR 394M 65M 2026-09
Hikma Pharmaceutical USD 348M 161M 2025-12
Lonza CHF 673M 243M 2025-06
Merck EUR 1.1B 51M 2026-06
Novartis USD 5.14B 392M 2026-09
Philips EUR 165M 445M 2026-09
Roche Holding CHF 11.46B 1.91B 2026-06
RWE EUR 1.38B 1.52B 2026-06
Sanofi EUR 4.72B 2.34B 2026-09
SAP EUR 926M 1.72B 2026-09
Smith & Nephew USD 505M 65M 2026-06